株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

人工多能性幹細胞(iPS細胞)の世界市場:市場規模、情勢、予測 2020年~2025年

Global Induced Pluripotent Stem Cells Market Size, Status and Forecast 2020-2025

発行 QYResearch 商品コード 797011
出版日 ページ情報 英文 103 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=111.91円で換算しております。
Back to Top
人工多能性幹細胞(iPS細胞)の世界市場:市場規模、情勢、予測 2020年~2025年 Global Induced Pluripotent Stem Cells Market Size, Status and Forecast 2020-2025
出版日: 2020年02月13日 ページ情報: 英文 103 Pages
概要

世界のiPS細胞(人工多能性幹細胞)市場は、2019年に8,052万米ドルと評価され、2020年から2025年の間に12.26%のCAGRで拡大し、2025年には1億6,091万米ドル規模の市場に成長すると予測されています。

当レポートでは、iPS細胞の世界市場を調査し、市場の概要、タイプ・用途・国別の市場規模の推移と予測、市場シェア、主要企業の収益額、市場成長の動向、主要企業のプロファイルなどをまとめています。

第1章 レポート概要

第2章 世界市場の成長動向

  • 市場規模
  • 成長動向:地域別
    • 市場規模:地域別
    • 市場シェア:地域別

第3章 主要企業の市場シェア

  • 市場規模:企業別
    • 収益額:企業別
    • 収益シェア:企業別
    • 市場集中度
  • 主要企業の生産拠点と事業エリア
  • 合併・買収・拡大計画

第4章 市場の内訳:タイプ・用途別

  • 市場規模:タイプ別(実績値)
  • 市場規模:用途別(実績値)

第5章 米国市場

  • 米国のiPS細胞(人工多能性幹細胞)市場
  • 主要企業
  • 市場規模:タイプ別
  • 市場規模:用途別

第6章 欧州市場

  • 欧州のiPS細胞(人工多能性幹細胞)市場
  • 主要企業
  • 市場規模:タイプ別
  • 市場規模:用途別

第7章 中国市場

  • 中国のiPS細胞(人工多能性幹細胞)市場
  • 主要企業
  • 市場規模:タイプ別
  • 市場規模:用途別

第8章 日本市場

  • 日本のiPS細胞(人工多能性幹細胞)市場
  • 主要企業
  • 市場規模:タイプ別
  • 市場規模:用途別

第9章 東南アジア市場

  • 東南アジアのiPS細胞(人工多能性幹細胞)市場
  • 主要企業
  • 市場規模:タイプ別
  • 市場規模:用途別

第10章 インド市場

  • インドのiPS細胞(人工多能性幹細胞)市場
  • 主要企業
  • 市場規模:タイプ別
  • 市場規模:用途別

第11章 中南米市場

  • 中南米のiPS細胞(人工多能性幹細胞)市場
  • 主要企業
  • 市場規模:タイプ別
  • 市場規模:用途別

第12章 主要企業のプロファイル

  • 富士フイルムホールディングス
  • Ncardia
  • 大日本住友製薬
  • アステラス製薬
  • Fate Therapeutics, Inc.
  • Pluricell Biotech
  • Cell Inspire Biotechnology
  • ReproCELL

第13章 市場予測

  • 市場規模の推移と予測
  • 米国
  • 欧州
  • 中国
  • 日本
  • 東南アジア
  • インド
  • 中南米
  • 市場規模の予測:製品別
  • 市場規模の予測:用途別

第14章 アナリストの考察と総論

第15章 付録

図表
  • Table Induced Pluripotent Stem Cells Key Market Segments 1
  • Table Induced Pluripotent Stem Cells Key Players Covered in 2018 2
  • Table Global Induced Pluripotent Stem Cells Market Size Growth Rate by Type (2020-2025) (Million US$) 3
  • Figure Global Induced Pluripotent Stem Cells Market Share by Type in 2020 & 2025 3
  • Table Global Induced Pluripotent Stem Cells Market Size Growth by Application (2020-2025) (Million US$) 4
  • Figure Global Induced Pluripotent Stem Cells Market Share by Application in 2020 & 2025 5
  • Figure Global Induced Pluripotent Stem Cells Market Size and Growth Rate 2014-2025 (Million US$) 7
  • Table Global Induced Pluripotent Stem Cells Market Size by Regions 2020-2025 (Million US$) 8
  • Figure Global Induced Pluripotent Stem Cells Market Size by Regions 2020-2025 (Million US$) 9
  • Table Global Induced Pluripotent Stem Cells Market Size by Regions 2014-2019 (Million US$) 9
  • Table Global Induced Pluripotent Stem Cells Market Share by Regions 2014-2019 10
  • Figure Global Induced Pluripotent Stem Cells Market Share by Regions 2014-2019 10
  • Figure Global Induced Pluripotent Stem Cells Market Share by Regions 2019 11
  • Table Global Induced Pluripotent Stem Cells Revenue by Players (2014-2019) (Million US$) 12
  • Table Global Induced Pluripotent Stem Cells Market Share by Players (2014-2019) 13
  • Figure Global Induced Pluripotent Stem Cells Market Share by Players in 2019 13
  • Table Global Induced Pluripotent Stem Cells Manufacturers Market Concentration Ratio (CR5) 14
  • Table Key Players Head office and Area Served 14
  • Table Global Induced Pluripotent Stem Cells Market Size by Type (2014-2019) (Million US$) 16
  • Table Global Induced Pluripotent Stem Cells Market Size Share by Type (2014-2019) 16
  • Figure Global Induced Pluripotent Stem Cells Market Size Market Share by Type (2014-2019) 17
  • Table Global Induced Pluripotent Stem Cells Market Size by Application (2014-2019) (Million US$) 17
  • Table Global Induced Pluripotent Stem Cells Market Size Share by Application (2014-2019) 18
  • Figure Global Induced Pluripotent Stem Cells Market Size Market Share by Application (2014-2019) 18
  • Figure Global Induced Pluripotent Stem Cells Revenue Market Share by Application in 2019 19
  • Figure United States Induced Pluripotent Stem Cells Market Size 2014-2019 (Million US$) 20
  • Table United States Key Players Induced Pluripotent Stem Cells Revenue (2018-2019) (Million US$) 20
  • Figure United States Key Players Induced Pluripotent Stem Cells Market Share in 2019 21
  • Figure United States Induced Pluripotent Stem Cells Market Share by Type in 2018 22
  • Figure United States Induced Pluripotent Stem Cells Market Share by Application in 2018 23
  • Figure Europe Induced Pluripotent Stem Cells Market Size 2014-2019 (Million US$) 24
  • Table Europe Key Players Induced Pluripotent Stem Cells Revenue (2018-2019) (Million US$) 24
  • Table Europe Key Players Induced Pluripotent Stem Cells Market Share in 2019 25
  • Figure Europe Induced Pluripotent Stem Cells Market Share by Type in 2018 26
  • Figure Europe Induced Pluripotent Stem Cells Market Share by Application in 2018 27
  • Figure China Induced Pluripotent Stem Cells Market Size 2014-2019 (Million US$) 28
  • Table China Key Players Induced Pluripotent Stem Cells Revenue (2018-2019) (Million US$) 28
  • Figure China Key Players Induced Pluripotent Stem Cells Market Share in 2019 29
  • Figure China Induced Pluripotent Stem Cells Market Share by Type in 2018 30
  • Figure China Induced Pluripotent Stem Cells Market Share by Application in 2018 31
  • Figure Japan Induced Pluripotent Stem Cells Market Size 2014-2019 (Million US$) 32
  • Table Japan Key Players Induced Pluripotent Stem Cells Revenue (2018-2019) (Million US$) 32
  • Figure Japan Key Players Induced Pluripotent Stem Cells Market Share in 2019 33
  • Figure Japan Induced Pluripotent Stem Cells Market Share by Type in 2018 34
  • Figure Japan Induced Pluripotent Stem Cells Market Share by Application in 2018 35
  • Figure Southeast Asia Induced Pluripotent Stem Cells Market Size 2014-2019 (Million US$) 36
  • Table Southeast Asia Key Players Induced Pluripotent Stem Cells Revenue (2018-2019) (Million US$) 36
  • Figure Southeast Asia Key Players Induced Pluripotent Stem Cells Market Share in 2019 37
  • Figure Southeast Asia Induced Pluripotent Stem Cells Market Share by Type in 2018 38
  • Figure Southeast Asia Induced Pluripotent Stem Cells Market Share by Application in 2018 39
  • Figure India Induced Pluripotent Stem Cells Market Size 2014-2019 (Million US$) 40
  • Table India Key Players Induced Pluripotent Stem Cells Revenue (2018-2019) (Million US$) 40
  • Figure India Key Players Induced Pluripotent Stem Cells Market Share in 2019 41
  • Figure India Induced Pluripotent Stem Cells Market Share by Type in 2018 42
  • Figure India Induced Pluripotent Stem Cells Market Share by Application in 2018 43
  • Figure Central & South America Induced Pluripotent Stem Cells Market Size 2014-2019 (Million US$) 44
  • Table Central & South America Key Players Induced Pluripotent Stem Cells Revenue (2018-2019) (Million US$) 44
  • Figure Central & South America Key Players Induced Pluripotent Stem Cells Market Share in 2019 45
  • Figure Central & South America Induced Pluripotent Stem Cells Market Share by Type in 2018 46
  • Figure Central & South America Induced Pluripotent Stem Cells Market Share by Application in 2018 47
  • Table Fujifilm Holding Corporation (CDI) Basic Information, Manufacturing Base, Sales Area and Its Competitors 48
  • Figure Induced Pluripotent Stem Cells Product Picture Examples of Fujifilm Holding Corporation (CDI) 49
  • Table Fujifilm Holding Corporation (CDI) Revenue in Induced Pluripotent Stem Cells Business (2014-2019) (Million US$) 50
  • Figure Fujifilm Holding Corporation (CDI) Revenue Growth Rate in Induced Pluripotent Stem Cells Business (2014-2019) 50
  • Figure Fujifilm Holding Corporation (CDI) Revenue Share in Induced Pluripotent Stem Cells Business (2014-2019) 51
  • Table Ncardia Basic Information, Manufacturing Base, Sales Area and Its Competitors 52
  • Figure Induced Pluripotent Stem Cells Product Picture Examples of Ncardia 53
  • Table Ncardia Revenue in Induced Pluripotent Stem Cells Business (2014-2019) (Million US$) 53
  • Figure Ncardia Revenue Growth Rate in Induced Pluripotent Stem Cells Business (2014-2019) 54
  • Figure Ncardia Revenue Share in Induced Pluripotent Stem Cells Business (2014-2019) 54
  • Table Sumitomo Dainippon Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors 55
  • Figure Induced Pluripotent Stem Cells Product Picture Examples of Sumitomo Dainippon Pharma 56
  • Table Sumitomo Dainippon Pharma Revenue in Induced Pluripotent Stem Cells Business (2014-2019) (Million US$) 56
  • Figure Sumitomo Dainippon Pharma Revenue Growth Rate in Induced Pluripotent Stem Cells Business (2014-2019) 57
  • Figure Sumitomo Dainippon Pharma Revenue Share in Induced Pluripotent Stem Cells Business (2014-2019) 57
  • Table Astellas Pharma Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors 58
  • Table Astellas Pharma Inc. Revenue in Induced Pluripotent Stem Cells Business (2014-2019) (Million US$) 59
  • Figure Astellas Pharma Inc. Revenue Growth Rate in Induced Pluripotent Stem Cells Business (2014-2019) 59
  • Figure Astellas Pharma Inc. Revenue Share in Induced Pluripotent Stem Cells Business (2014-2019) 60
  • Table Fate Therapeutics, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors 61
  • Figure Induced Pluripotent Stem Cells Product Picture Examples of Fate Therapeutics, Inc. 62
  • Table Fate Therapeutics, Inc. Revenue in Induced Pluripotent Stem Cells Business (2014-2019) (Million US$) 62
  • Figure Fate Therapeutics, Inc. Revenue Growth Rate in Induced Pluripotent Stem Cells Business (2014-2019) 63
  • Figure Fate Therapeutics, Inc. Revenue Share in Induced Pluripotent Stem Cells Business (2014-2019) 63
  • Table Pluricell Biotech Basic Information, Manufacturing Base, Sales Area and Its Competitors 64
  • Figure Induced Pluripotent Stem Cells Product Picture Examples of Pluricell Biotech 65
  • Table Pluricell Biotech Revenue in Induced Pluripotent Stem Cells Business (2014-2019) (Million US$) 65
  • Figure Pluricell Biotech Revenue Growth Rate in Induced Pluripotent Stem Cells Business (2014-2019) 66
  • Figure Pluricell Biotech Revenue Share in Induced Pluripotent Stem Cells Business (2014-2019) 66
  • Table Cell Inspire Biotechnology Basic Information, Manufacturing Base, Sales Area and Its Competitors 67
  • Figure Induced Pluripotent Stem Cells Product Specification Examples of Cell Inspire Biotechnology 68
  • Table Cell Inspire Biotechnology Revenue in Induced Pluripotent Stem Cells Business (2014-2019) (Million US$) 68
  • Figure Cell Inspire Biotechnology Revenue Growth Rate in Induced Pluripotent Stem Cells Business (2014-2019) 69
  • Figure Cell Inspire Biotechnology Revenue Share in Induced Pluripotent Stem Cells Business (2014-2019) 69
  • Table ReproCELL Basic Information, Manufacturing Base, Sales Area and Its Competitors 70
  • Figure Induced Pluripotent Stem Cells Product Picture Examples of ReproCELL 71
  • Figure Induced Pluripotent Stem Cells Product Specification Examples of ReproCELL 71
  • Table ReproCELL Revenue in Induced Pluripotent Stem Cells Business (2014-2019) (Million US$) 72
  • Figure ReproCELL Revenue Growth Rate in Induced Pluripotent Stem Cells Business (2014-2019) 72
  • Figure ReproCELL Revenue Share in Induced Pluripotent Stem Cells Business (2014-2019) 73
  • Table Global Induced Pluripotent Stem Cells Market Size by Regions (Million US$) 2020-2025 74
  • Figure Global Induced Pluripotent Stem Cells Market Size Share by Regions (2020-2025) 74
  • Figure Global Induced Pluripotent Stem Cells Market Size Share by Regions in 2025 75
  • Figure United States Induced Pluripotent Stem Cells Market Size Forecast (2020-2025) (Million USD) 76
  • Figure Europe Induced Pluripotent Stem Cells Market Size Forecast (2020-2025) (Million USD) 77
  • Figure China Induced Pluripotent Stem Cells Market Size Forecast (2020-2025) (Million USD) 78
  • Figure Japan Induced Pluripotent Stem Cells Market Size Forecast (2020-2025) (Million USD) 79
  • Figure Southeast Asia Induced Pluripotent Stem Cells Market Size Forecast (2020-2025) (Million USD) 80
  • Figure India Induced Pluripotent Stem Cells Market Size Forecast (2020-2025) (Million USD) 81
  • Figure Central & South America Induced Pluripotent Stem Cells Market Size Forecast (2020-2025) (Million USD) 82
  • Table Global Induced Pluripotent Stem Cells Market Size by Product (2020-2025) (Million USD) 82
  • Figure Global Induced Pluripotent Stem Cells Market Size by Product (2020-2025) 83
  • Figure Global Induced Pluripotent Stem Cells Market Size by Product in 2025 83
  • Table Global Induced Pluripotent Stem Cells Market Size by Application (w (Million USD) 84
  • Figure Global Induced Pluripotent Stem Cells Market Size by Application (2020-2025) 84
  • Figure Global Induced Pluripotent Stem Cells Market Size by Application in 2025 85
  • Table Research Programs/Design for This Report 87
  • Figure Bottom-up and Top-down Approaches for This Report 89
  • Figure Data Triangulation 90
  • Figure Key Executives Interviewed 91
  • Table Key Data Information from Secondary Sources 92
  • Table Key Data Information from Primary Sources 93
目次

In 2019, the global Induced Pluripotent Stem Cells market size was 80.52 million US$ and it is expected to reach 160.91 million US$ by the end of 2025, with a CAGR of 12.26% during 2020-2025.

This report focuses on the global Induced Pluripotent Stem Cells status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Induced Pluripotent Stem Cells development in United States, Europe, China, Japan, Southeast Asia, India, Central & South America and Other Regions

The key players covered in this study

Fujifilm Holding Corporation (CDI)

Ncardia

Sumitomo Dainippon Pharma

Astellas Pharma Inc

Fate Therapeutics, Inc

Pluricell Biotech

Cell Inspire Biotechnology

ReproCELL

Market segment by Type, the product can be split into

Human iPSCs

Mouse iPSCs

Market segment by Application, split into

Academic Research

Drug Development and Discovery

Toxicity Screening

Regenerative Medicine

Others

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Central & South America

Other Regions

1 Report Overview 1

  • 1.1 Study Scope 1
  • 1.2 Key Market Segments 1
  • 1.3 Players Covered 2
  • 1.4 Market Analysis by Type 2
  • 1.5 Market by Application 3
  • 1.6 Study Objectives 5
  • 1.7 Years Considered 5

2 Global Growth Trends 7

  • 2.1 Global Induced Pluripotent Stem Cells Market Size 7
  • 2.2 Induced Pluripotent Stem Cells Growth Trends by Regions 8
    • 2.2.1 Induced Pluripotent Stem Cells Market Size by Regions (2020-2025) 8
    • 2.2.2 Induced Pluripotent Stem Cells Market Share by Regions (2014-2019) 9

3 Market Share by Key Players 12

  • 3.1 Induced Pluripotent Stem Cells Market Size by Players 12
    • 3.1.1 Global Induced Pluripotent Stem Cells Revenue by Players (2014-2019) 12
    • 3.1.2 Global Induced Pluripotent Stem Cells Revenue Market Share by Players (2014-2019) 13
    • 3.1.3 Global Induced Pluripotent Stem Cells Market Concentration Ratio (CR5) 14
  • 3.2 Induced Pluripotent Stem Cells Key Players Manufacturing Sites and Area Served 14
  • 3.3 Mergers & Acquisitions, Expansion Plans 15

4 Breakdown Data by Type and Application 16

  • 4.1 Global Induced Pluripotent Stem Cells Market Size by Type (2014-2019) 16
  • 4.2 Global Induced Pluripotent Stem Cells Market Size by Application (2014-2019) 17

5 United States 20

  • 5.1 United States Induced Pluripotent Stem Cells Market (2014-2019) 20
  • 5.2 Induced Pluripotent Stem Cells Key Players in United States 20
  • 5.3 United States Induced Pluripotent Stem Cells Market Size by Type 22
  • 5.4 United States Induced Pluripotent Stem Cells Market Size by Application 23

6 Europe 24

  • 6.1 Europe Induced Pluripotent Stem Cells Market (2014-2019) 24
  • 6.2 Induced Pluripotent Stem Cells Key Players in Europe 24
  • 6.3 Europe Induced Pluripotent Stem Cells Market Size by Type 26
  • 6.4 Europe Induced Pluripotent Stem Cells Market Size by Application 27

7 China 28

  • 7.1 China Induced Pluripotent Stem Cells Market (2014-2019) 28
  • 7.2 Induced Pluripotent Stem Cells Key Players in China 28
  • 7.3 China Induced Pluripotent Stem Cells Market Size by Type 30
  • 7.4 China Induced Pluripotent Stem Cells Market Size by Application 31

8 Japan 32

  • 8.1 Japan Induced Pluripotent Stem Cells Market (2014-2019) 32
  • 8.2 Induced Pluripotent Stem Cells Key Players in Japan 32
  • 8.3 Japan Induced Pluripotent Stem Cells Market Size by Type 34
  • 8.4 Japan Induced Pluripotent Stem Cells Market Size by Application 35

9 Southeast Asia 36

  • 9.1 Southeast Asia Induced Pluripotent Stem Cells Market (2014-2019) 36
  • 9.2 Induced Pluripotent Stem Cells Key Players in Southeast Asia 36
  • 9.3 Southeast Asia Induced Pluripotent Stem Cells Market Size by Type 38
  • 9.4 Southeast Asia Induced Pluripotent Stem Cells Market Size by Application 39

10 India 40

  • 10.1 India Induced Pluripotent Stem Cells Market (2014-2019) 40
  • 10.2 Induced Pluripotent Stem Cells Key Players in India 40
  • 10.3 India Induced Pluripotent Stem Cells Market Size by Type 42
  • 10.4 India Induced Pluripotent Stem Cells Market Size by Application 43

11 Central & South America 44

  • 11.1 Central & South America Induced Pluripotent Stem Cells Market (2014-2019) 44
  • 11.2 Induced Pluripotent Stem Cells Key Players in Central & South America 44
  • 11.3 Central & South America Induced Pluripotent Stem Cells Market Size by Type 46
  • 11.4 Central & South America Induced Pluripotent Stem Cells Market Size by Application 47

12 Key Players Profiles 48

  • 12.1 Fujifilm Holding Corporation (CDI) 48
    • 12.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 48
    • 12.1.2 Induced Pluripotent Stem Cells Product Overview 49
    • 12.1.3 Fujifilm Holding Corporation (CDI) Revenue in Induced Pluripotent Stem Cells Business (2014-2019) 50
    • 12.1.4 Main Business/Business Overview 51
  • 12.2 Ncardia 52
    • 12.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 52
    • 12.2.2 Induced Pluripotent Stem Cells Product Overview 53
    • 12.2.3 Ncardia Revenue in Induced Pluripotent Stem Cells Business (2014-2019) 53
    • 12.2.4 Main Business/Business Overview 55
  • 12.3 Sumitomo Dainippon Pharma 55
    • 12.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 55
    • 12.3.2 Induced Pluripotent Stem Cells Product Overview 56
    • 12.3.3 Sumitomo Dainippon Pharma Revenue in Induced Pluripotent Stem Cells Business (2014-2019) 56
    • 12.3.4 Main Business/Business Overview 58
  • 12.4 Astellas Pharma Inc. 58
    • 12.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 58
    • 12.4.2 Induced Pluripotent Stem Cells Product Overview 59
    • 12.4.3 Astellas Pharma Inc. Revenue in Induced Pluripotent Stem Cells Business (2014-2019) 59
    • 12.4.4 Main Business/Business Overview 60
  • 12.5 Fate Therapeutics, Inc. 61
    • 12.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 61
    • 12.5.2 Induced Pluripotent Stem Cells Product Overview 62
    • 12.5.3 Fate Therapeutics, Inc. Revenue in Induced Pluripotent Stem Cells Business (2014-2019) 62
    • 12.5.4 Main Business/Business Overview 64
  • 12.6 Pluricell Biotech 64
    • 12.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 64
    • 12.6.2 Induced Pluripotent Stem Cells Product Overview 65
    • 12.6.3 Pluricell Biotech Revenue in Induced Pluripotent Stem Cells Business (2014-2019) 65
    • 12.6.4 Main Business/Business Overview 67
  • 12.7 Cell Inspire Biotechnology 67
    • 12.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 67
    • 12.7.2 Induced Pluripotent Stem Cells Product Overview 68
    • 12.7.3 Cell Inspire Biotechnology Revenue in Induced Pluripotent Stem Cells Business (2014-2019) 68
    • 12.7.4 Main Business/Business Overview 70
  • 12.8 ReproCELL 70
    • 12.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 70
    • 12.8.2 Induced Pluripotent Stem Cells Product Overview 71
    • 12.8.3 ReproCELL Revenue in Induced Pluripotent Stem Cells Business (2014-2019) 72
    • 12.8.4 Main Business/Business Overview 73

13 Market Forecast 2020-2025 74

  • 13.1 Market Size Forecast by Regions 74
  • 13.2 United States 76
  • 13.3 Europe 77
  • 13.4 China 78
  • 13.5 Japan 79
  • 13.6 Southeast Asia 80
  • 13.7 India 81
  • 13.8 Central & South America 82
  • 13.9 Market Size Forecast by Product (2020-2025) 82
  • 13.10 Market Size Forecast by Application (2020-2025) 84

14 Analyst's Viewpoints/Conclusions 86

15 Appendix 87

  • 15.1 Research Methodology 87
    • 15.1.1 Methodology/Research Approach 87
    • 15.1.2 Data Source 91
  • 15.2 Disclaimer 93
  • 15.3 Author Details 94
Back to Top